PLSE Pulse Biosciences, Inc.

NASDAQ
$53.87

Pulse Biosciences, Inc. (PLSE) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bullish Insiders bought more than they sold over this window — uncommon at any size.
Cluster activity 1 buyer in the last 30 days 1 buyer in the last 90 days 0 sellers in the last 90 days
Insiders buying
3
8 transactions
Insiders selling
1
9 transactions
Purchases
$26.8M
1,354,561 shares
Sales
$3.0M
130,000 shares
Net activity
$23.8M
purchases less sales

How much of that selling was preplanned? 100% planned / 0% discretionary

10b5-1 plan sales $3.0M 9 transactions · 130,000 shares
Discretionary sales $0 0 transactions · 0 shares

Largest single sale: $504.0K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: September 1, 2026 , by Teplitsky Liane Rae .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Teplitsky Liane Rae Chief Operating Officer Buy 1,001 $49.95 $50.0K 4,095
Teplitsky Liane Rae Chief Operating Officer Buy 1,024 $48.80 $50.0K 3,094
Teplitsky Liane Rae Chief Operating Officer Buy 1,034 $48.35 $50.0K 2,070
Teplitsky Liane Rae Chief Operating Officer Buy 1,036 $48.23 $50.0K 1,036
DUGGAN ROBERT W 2 fills Director Buy 1,320,466 $19.69 $26.0M 48,370,047
LAVIOLETTE PAUL A 2 fills Chief Executive Officer Buy 30,000 $19.69 $590.7K 15,846
Danahy Kevin Patrick Chief Commercial Officer Sell 10b5-1 5,000 $23.64 $118.2K 43,298 −10.4% of holding
Danahy Kevin Patrick Chief Commercial Officer Sell 10b5-1 20,000 $23.63 $472.6K 43,298 −31.6% of holding
Danahy Kevin Patrick Chief Commercial Officer Sell 10b5-1 20,000 $23.53 $470.6K 43,298 −31.6% of holding
Danahy Kevin Patrick Chief Commercial Officer Sell 10b5-1 20,000 $23.37 $467.4K 43,298 −31.6% of holding
Danahy Kevin Patrick Chief Commercial Officer Sell 10b5-1 20,000 $25.20 $504.0K 43,298 −31.6% of holding
Danahy Kevin Patrick Chief Commercial Officer Sell 10b5-1 20,000 $23.52 $470.4K 43,298 −31.6% of holding
Danahy Kevin Patrick Chief Commercial Officer Sell 10b5-1 20,000 $21.45 $429.0K 43,298 −31.6% of holding
Danahy Kevin Patrick Chief Commercial Officer Sell 10b5-1 4,600 $18.53 $85.2K 43,298 −9.6% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.